News
$Liquidia (LQDA.US)$ Reuters
·1 min ago
U.S. FDA Grants Tentative Approval of Yutrepia™ (Treprostinil) Inhalation Powder for Patients With Pulmonary Arterial Hypertension (Pah) and Pulmonary Hypertension Associated With Interstitial Lung Disease (Ph-Ild)
·1 min ago
U.S. FDA Grants Tentative Approval of Yutrepia™ (Treprostinil) Inhalation Powder for Patients With Pulmonary Arterial Hypertension (Pah) and Pulmonary Hypertension Associated With Interstitial Lung Disease (Ph-Ild)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Trytosaveabit OP : FDA Confirmed That Amendment to Add Ph-Ild to Yutrepia Nda Meets Requirements for Approval Under Federal Food, Drug, and Cosmetic Act.
Nilco : Thats a sharp dive![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Trytosaveabit OP Nilco : Hardly any volume yet. Also remember it’s damn near 30% SI. Also it’s only a tentative approval!
Nilco Trytosaveabit OP :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")